Cullinan Therapeutics, Inc.
Balance Sheet
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $115.0M | $74.2M | $98.4M | $64.8M | $141.8M | $122.1M | $156.2M | $242.7M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $677.8M | $445.7M | $480.2M | $476.7M | $498.2M | $399.0M | $474.5M | $582.1M |
| Property, Plant & Equipment | $836.0K | $913.0K | $989.0K | $1.1M | $1.2M | $1.2M | $1.2M | $792.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $681.2M | $449.4M | $484.2M | $494.7M | $522.0M | $515.0M | $561.1M | $617.2M |
| Liabilities | ||||||||
| Accounts Payable | $1.6M | $3.7M | $2.5M | $951.0K | $2.5M | $2.0M | $2.7M | $1.5M |
| Total Current Liabilities | $23.5M | $21.9M | $28.1M | $23.4M | $19.7M | $26.2M | $22.5M | $27.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $25.0M | $23.8M | $30.3M | $25.9M | $22.4M | $29.3M | $26.1M | $31.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-280.0M | $-238.0M | $-200.9M | $-177.1M | $-137.9M | $-105.7M | $-47.7M | $-20.9M |
| Total Stockholders' Equity | $656.2M | $425.7M | $453.7M | $468.8M | $499.6M | $485.6M | $535.0M | $586.1M |